Krka Looks to be Off the Hook over Simvastatin
Novo Mesto, 2 June - The Ljubljana District Court has rejected a patent lawsuit of US pharma giant Merck against Slovenian pharmaceutical company Krka over the drug Simvastatin. Krka said this in a press release on Thursday.
The rest of this news item is available to subscribers.
The news item consists of 571 characters (without spaces) or 110 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.